Dextroamphetamine recalls

The FDA has published 10 recalls involving Dextroamphetamine since 2013. The latest was reported on 27 Nov 2024. Most were for potency & assay. Amedra Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls10since 2013

Last 12 months0reported

Class I110% of total

Ongoing1latest 27 Nov 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 1 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 10%Class II 9 90%Class III 0 0%

Why dextroamphetamine is recalled

Potency & Assay880%
Packaging Defects220%

Companies

Brands

By year

2024220%
2016330%
2015110%
2014110%
2013330%

Ongoing dextroamphetamine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
27 Nov 2024Drug	CLASS II	Xelstrym (dextroamphetamine) transdermal system recalledXelstrym	Noven Pharmaceuticals	Packaging Defects	Nationwide

All dextroamphetamine recalls, newest first

10 total

Reported	Class	Recall	Company	Reason	Where
27 Nov 2024Drug	CLASS II	Xelstrym (dextroamphetamine) transdermal system recalledXelstrym	Noven Pharmaceuticals	Packaging Defects	Nationwide
7 Feb 2024Drug	CLASS I	Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg recalledZenzedi	Azurity Pharmaceuticals	Packaging Defects	Nationwide
3 Aug 2016Drug	CLASS II	Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg recalledDextroamphetamine Sulfate	Actavis	Potency & Assay	Nationwide
27 Apr 2016Drug	CLASS II	Dextroamphetamine Sulfate Tablets USP, 5 mg recalled	Impax Laboratories	Potency & Assay	Nationwide
27 Apr 2016Drug	CLASS II	Dextroamphetamine Sulfate Tablets USP, 10 mg recalled	Impax Laboratories	Potency & Assay	Nationwide
11 Mar 2015Drug	CLASS II	Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg recalledDextroamphetamine Sulfate	Actavis Elizabeth	Potency & Assay	Nationwide
2 Jul 2014Drug	CLASS II	Dextroamphetamine Sulfate Tablets, USP, 10 mg recalledDextroamphetamine Sulfate	Teva Pharmaceuticals U	Potency & Assay	Nationwide
6 Mar 2013Drug	CLASS II	Dextroamphetamine Sulfate Extended Release Capsules, 5 mg recalled	Amedra Pharmaceuticals	Potency & Assay	Nationwide
6 Mar 2013Drug	CLASS II	Dextroamphetamine Sulfate Extended Release Capsules, 5 mg recalled	Amedra Pharmaceuticals	Potency & Assay	Nationwide
6 Mar 2013Drug	CLASS II	Dextroamphetamine Sulfate Extended Release Capsules, 5 mg recalled	Amedra Pharmaceuticals	Potency & Assay	Nationwide

Should you stop taking Dextroamphetamine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.